Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (2883)	11/19/1997 2:17:00 PM
From: billkirn	Read Replies (1) \| Respond to of 6136

Izzy: It seems to be building a base here? My guess is the 39 point is pretty important. If it goes below this point, I would expect it to test the 32 point. Not a pretty sight for those who own options like me. If you have unlimited resources, and it breaks 39, the 32-35 could be a great long term buy point. Personally I am exercizing some of my options. The two charts I still follow have yet to show a turn around coming. My sense is it could go to its normal low point of around 20% below its 200 day moving average (~35). It did this around July 1996. Also, a very unusual occurance, the 200ma has turned down and with the stock below its 200ma it could produced longer periods of retracement than one likes to think. Remember, stocks will move to their extremes. It has been pretty hot over the last 16 months. The perception right now seems to be less than super positive and exciting, so the stock price will probably find a place that reflects this perception. I am sure this will change in time, but maybe not in the right time. To leverage or gamble has its difficult moments. Bill sonic.net 0r sonic.net

To: Izzy who wrote (2883)	11/19/1997 5:15:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Izzy...I'll bet a lot of us are concerned. The stock will likely continue to trend downwards if the lack of news continues. There appear to be too many if's remaining to support the stock at these P/E levels. The supporting analysts have clammed up, other than internal documents released to sooth nervous investors, and the company dosen't release any news. If Austrailian approval has happened, or is about to happen, they should let investors know, along with expected inpact to the bottom line. I don't buy that '98 estimates include anything but US sales. Agoroun should clarify this. I will write them and ask. sf